A new 25-page report commissioned by the European Federation of Pharmaceutical Industries and Associations ( EFPIA ) has highlighted the serious risks posed to public health by the relocation of the European Medicines Agency (EMA). The relocation will restrict the agency s ability to callOriginal Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.